Karolinska Development AB (publ) (KDEV.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Viktor Drvota M.D., Ph.D. | Chief Executive Officer | 4.82M | -- | 1965 |
| Mr. Hans Christopher Toll | Chief Financial Officer | -- | -- | 1968 |
| Ms. Mikaela Sörman | Investment Manager | -- | -- | 1990 |
| Ms. Eva Montgomerie | Head of Accounting | -- | -- | 1958 |
| Dr. John Öhd M.D., Ph.D. | Chief Scientific Officer & Venture Partner | -- | -- | 1971 |
| Mr. Johan Dighed | Chief Legal Officer & Deputy CEO | -- | -- | 1973 |
| Mr. Tse Ping | Senior Strategic Advisor | -- | -- | 1952 |
Karolinska Development AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 8
Description
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
Corporate Governance
Upcoming Events
April 30, 2025 at 6:00 AM UTC
Karolinska Development AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available